The pharmacology of donepezil: a new treatment for Alzheimer’s disease

Author： Wilkinson D.G.  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.1, 1999-11, pp. : 121-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease

By Wilcock G.  

Drugs & Aging, Vol. 20, Iss. 10, 2003-01 ,pp. : 777-789

Adis International

Access to resources Recommend Favorite

Donepezil: An Important Prototype to the Design of New Drug Candidates for Alzheimer’s Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 2-19

Bentham Science Publishers

Access to resources Recommend Favorite

Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease

By Heydorn W.E.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1527-1537

Informa Healthcare

Access to resources Recommend Favorite

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 17, Iss. 1, 2018-04 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

By Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite